Lendio, Yulie S.

HRN: 26-51-26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/11/2025
01/15/2025
IV
600mg
Q6h
Cellulitis, L Foot
Waiting Final Action 
01/11/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/11/2025
01/18/2025
IV
4.5g
Q8h
Cellulitis, L Foot
Waiting Final Action 
01/16/2025
AZITHROMYCIN 500MG TABLET (TAB)
01/16/2025
01/23/2025
PO
500mg
OD
CAP MR
Waiting Final Action 
01/19/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/19/2025
01/26/2025
IV
2.25gms
Q8
Cellulitis
Waiting Final Action 
01/19/2025
CLINDAMYCIN 300MG (CAP)
01/19/2025
01/26/2025
PO
300mg
TID
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: